Overall survival | Disease-free survival | |||||
---|---|---|---|---|---|---|
Variables | HR | CI95% | P-value | HR | CI95% | P-value |
FBL (set 1) | ||||||
Intermediate | 1.00 | 0.0150* | 1.00 | 0.0065** | ||
Low | 2.01 | [1.25–3.23] | 2.06 | [1.30–3.27] | ||
High | 1.40 | [0.84–2.34] | 1.51 | [0.93–2.45] | ||
FBL (set 2) | ||||||
Intermediate | 1.00 | 0.0615 | 1.00 | 0.0815 | ||
Low | 1.69 | [1.04–2.75] | 1.58 | [0.99–2.53] | ||
High | 1.53 | [0.92–2.54] | 1.52 | [0.94–2.46] | ||
NHP2L1 | ||||||
Intermediate | 1.00 | 0.0763 | 1.00 | 0.0538 | ||
Low | 1.67 | [1.05–2.66] | 1.74 | [1.11–2.72] | ||
High | 1.05 | [0.63–1.75] | 1.20 | [0.74–1.93] | ||
NOP56 | ||||||
Intermediate | 1.00 | 1.00 | 0.0604 | |||
Low | 1.52 | [0.93–2.50] | 0.1165 | 1.46 | [0.90–2.36] | |
High | 1.54 | [0.96–2.46] | 1.67 | [1.07–2.61] | ||
NOP58 | ||||||
High | 1.00 | 0.0031** | 1.00 | 0.0078** | ||
Low | 2.01 | [1.27–3.20] | 1.84 | [1.17–2.88] |